Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5615416 | Journal of Clinical Lipidology | 2016 | 26 Pages |
Abstract
FH is often underdiagnosed and suboptimally treated in clinical practice. Statin therapy in this population rarely went beyond low-moderate doses. These findings support EHR-based population health efforts to initiate an FH cascade-screening model and ensure higher quality care for this high-risk population and identify those who may benefit from advanced therapy.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Thomas MD, FACC, Matthew MS, Ross MS, Michael D. MD, MPH, Craig MD, MPH, Jeffrey J. PhD,